Exhibit 107
Calculation of Filing Fee Tables
FORM F-1
(Form Type)
NLS Pharmaceutics Ltd.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered and Carry Forward Securities
| Security Type | Security Class Title(1) | Fee Calculation or Carry Forward Rule | Amount Registered(1) | Proposed Maximum Offering Price Per Unit(2)(3) | Maximum Aggregate Offering Price | Fee Rate | Amount of Registration Fee | |
| Newly Registered Securities | ||||||||
Fees to Be Paid | Equity | Common Shares, par value CHF 0.02 | Rule 457(c) | 3,150,000(4) | $.6456 | $2,033,640 | $0.0000927 | $188.52 |
Fees Previously Paid | - | - | - | - | - | - | - | - |
| Total Offering Amounts | $2,033,640 | $188.52 | ||||||
| Total Fees Previously Paid | $0.00 | |||||||
| Total Fee Offsets | $0.00 | |||||||
| Net Fee Due | $188.52 | |||||||
| (1) | Pursuant to Rule 416 under the Securities Act of 1933, as amended, or the Securities Act, the Common Shares, par value CHF 0.02 per share, or Common Shares, issuable upon the exercise of the warrants, that are registered hereby also include an indeterminate number of additional Common Shares as may from time to time become issuable by reason of stock splits, stock dividends, recapitalizations or other similar transactions. |
| (2) | Estimated solely for purposes of calculating the amount of the registration fee pursuant to Rule 457(c) under the Securities Act, based on the average of the high and low sales prices of the Common Shares on the Nasdaq Capital Market on June 7, 2022. |
| (3) | The Registrant will not receive any proceeds from the sale of its Common Shares by the selling shareholders. |
| (4) | All 3,150,000 Ordinary Common are to be offered for resale by the selling shareholders named in the prospectus contained in this Registration Statement on Form F-1. |
